A dysregulation of AMPK signaling, particularly highlighted by a hyperactivation of the kinase, has been reported in ALS as well as in other neurodegenerative disorders (reviewed in [18]); however, it remains debated as to whether it is beneficial or detrimental, or if it merely reflects excessive cellular stress. The gene discussed is PRKAA1; the disease is amyotrophic lateral sclerosis.